• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

Alkaloids from Erythrina crista-galli flowers inhibit acetylcholinesterase

by
October 20, 2026
in Technology
Reading Time: 3 mins read
0
Alkaloids from Erythrina crista-galli flowers inhibit acetylcholinesterase

Alkaloids from Erythrina crista-galli flowers inhibit acetylcholinesterase

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Alkaloids isolated from Erythrina crista-galli flowers inhibited acetylcholinesterase in laboratory experiments, with cristamidine showing the strongest activity among four compounds tested. The study combined in vitro assays with molecular docking and molecular dynamics simulations to examine the compounds’ inhibitory activities and their interactions with the enzyme. Acetylcholinesterase, abbreviated AChE, is a hydrolytic enzyme that breaks down acetylcholine into choline and acetate.

The researchers noted that increased AChE activity in patients with Alzheimer’s disease may contribute to early degeneration of cholinergic neurons in the basal forebrain and to impaired cholinergic signalling. The experiments reported here evaluated enzyme inhibition, not effects on patients or on Alzheimer’s disease outcomes. Four alkaloids were isolated from E. crista-galli flowers: cristamidine, erythrinine, erythraline and 8-oxoerythrinine.

The researchers confirmed their structures using high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. These methods established the identities and structural features of the compounds before their inhibitory activity was assessed. In the in vitro assay, the four compounds were tested at a concentration of 50 micrograms per millilitre.

Cristamidine produced the highest inhibition effect, followed by 8-oxoerythrinine, erythrinine and erythraline. The supplied study abstract does not report exact inhibition percentages, concentration-response measurements or numerical values for the lower-ranking compounds, so the reported result establishes a ranking at the tested concentration rather than a complete pharmacological profile. The researchers then used molecular docking to investigate how the compounds might interact with AChE.

The simulations showed that both cristamidine and 8-oxoerythrinine formed stable interactions with AChE’s active pocket, linking the two strongest laboratory performers with computationally predicted binding behaviour. In the study, this analysis supported the observation that cristamidine and 8-oxoerythrinine formed stable interactions with the active pocket. The computational results are model-based findings and therefore complement, rather than independently establish, the measured inhibition seen in the laboratory assay.

The in vitro results show that the isolated alkaloids affected AChE under the assay conditions, while the in silico analyses indicate that two of the compounds, particularly cristamidine and 8-oxoerythrinine, interacted with the enzyme’s active site in the models. The authors identified E. crista-galli as a possible natural source of AChE inhibitors on the basis of these findings. The results remain confined to laboratory and computational studies.

No animal experiments, clinical studies or human outcomes were reported in the supplied material, and the findings do not demonstrate that the compounds or flowers treat Alzheimer’s disease or any other condition in people. The study instead establishes a set of chemically identified flower alkaloids with measured AChE inhibition and model-based evidence of stable interactions for two leading compounds.

Subject of Research: In vitro and in silico assessment of Erythrina crista-galli flower alkaloids as acetylcholinesterase inhibitors

Article Title: Alkaloids from Erythrina crista-galli flowers and their inhibitory activities against acetylcholinesterase: in vitro and in silico studies

Article References: Herlina, T., Akili, A. W. R., Hardianto, A., Fajriah, S., Handayani, S., Mayanti, T., Julaeha, E., & Latip, J. (2026). Alkaloids from Erythrina crista-galli flowers and their inhibitory activities against acetylcholinesterase: in vitro and in silico studies. Scientific Reports. https://doi.org/10.1038/s41598-026-76749-6

Image Credits: AI Generated

DOI: 10.1038/s41598-026-76749-6

Keywords: Erythrina crista-galli, acetylcholinesterase, plant alkaloids, cristamidine, 8-oxoerythrinine, in vitro assay, molecular docking, molecular dynamics, natural products, Alkaloids, Erythrina, crista-galli

News Source: Cassandra Pierce. (October 20, 2026). Alkaloids from Erythrina crista-galli flowers inhibit acetylcholinesterase. Scienmag.

Tags: 8-oxoerythrinineacetylcholinesterasealkaloidscrista-gallicristamidineErythrinaErythrina crista-galliin vitro assaymolecular dockingmolecular dynamicsnatural productsplant alkaloids
Share12Tweet7Share2ShareShareShare1

Related Posts

Autoencoder clustering boosts federated sentiment analysis under label skew

Autoencoder clustering boosts federated sentiment analysis under label skew

October 20, 2026
Lanthanum-tuned PtCo intermetallic catalyst improves oxygen-reduction activity in fuel-cell study

Lanthanum-tuned PtCo intermetallic catalyst improves oxygen-reduction activity in fuel-cell study

October 20, 2026

Ultrasound-activated channel improves glucose control in diabetic mice within dose window

October 20, 2026

Multi-agent framework evaluates factual narratives in 100 legal consultations

October 20, 2026

POPULAR NEWS

  • Metformin Leaves No Robust Gene Signature in Small AMD Trial

    Metformin Leaves No Robust Gene Signature in Small AMD Trial

    29 shares
    Share 12 Tweet 7
  • Fused UAV data improve winter wheat biomass estimates in two-season field study

    29 shares
    Share 12 Tweet 7
  • Ultrasound imaging measures keloids; patient-level vascular change uncertain

    29 shares
    Share 12 Tweet 7
  • Alkaloids from Erythrina crista-galli flowers inhibit acetylcholinesterase

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Metformin Leaves No Robust Gene Signature in Small AMD Trial

Fused UAV data improve winter wheat biomass estimates in two-season field study

Ultrasound imaging measures keloids; patient-level vascular change uncertain

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.